High coagulation factor levels and low protein C levels contribute to enhanced thrombin generation in patients with diabetes who do not have macrovascular complications

Journal of Diabetes and its Complications

Volumn 28, Issue 3, 2014, Pages 365-369

  Kim, Hyun Kyung ^a   Kim, Ji Eun ^a   Park, So Hyun ^b   Kim, Young Il ^b   Nam Goong, Il Sung ^b   Kim, Eun Sook ^b  

^a Seoul National University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Angiotensin receptor blocker; Coagulation factors; Patients with diabetes; Statins; Thrombin generation assay

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT PROTEIN; ANTITHROMBIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; C PEPTIDE; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; PROTEIN C; PROTHROMBIN; THROMBIN; THROMBOMODULIN; THROMBOPLASTIN; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; ALBUMIN BLOOD LEVEL; ALBUMINURIA; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETIC HYPERTENSION; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPERGLYCEMIA; HYPOCOAGULABILITY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; THROMBIN GENERATION ASSAY; THROMBIN TIME; THROMBOCYTE POOR PLASMA; AGED; INCIDENCE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; THROMBOPHILIA;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOSTASIS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN C; THROMBIN; THROMBOPHILIA;

EID: 84899564984     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2014.01.006     Document Type: Article

References (28)

1. R. Al Dieri, F. Peyvandi, E. Santagostino, M. Giansily, P.M. Mannucci, and J.F. Schved et al. The thrombogram in rare inherited coagulation disorders: Its relation to clinical bleeding Thrombosis and haemostasis 88 4 2002 576 582
2. American Diabetes Association Standards of medical care in diabetes - 2011 Diabetes Care 34 Suppl. 1 2011 S11 S61
3. L. Ay, F. Hoellerl, C. Ay, J.M. Brix, S. Koder, and G.H. Schernthaner et al. Thrombin generation in type 2 diabetes with albuminuria and macrovascular disease European journal of clinical investigation 42 5 2012 470 477
4. H.J. Beijers, I. Ferreira, H.M. Spronk, B. Bravenboer, J.M. Dekker, and G. Nijpels et al. Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: Potential role of central adiposity and low-grade inflammation - The Hoorn Study Thrombosis research 129 5 2012 557 562
5. A. Bierhaus, T. Illmer, M. Kasper, T. Luther, P. Quehenberger, and H. Tritschler et al. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE Circulation 96 7 1997 2262 2271
6. E. Castoldi, and J. Rosing APC resistance: Biological basis and acquired influences Journal of thrombosis and haemostasis 8 3 2010 445 453
7. A. Ceriello, A. Quatraro, P. Dello Russo, E. Marchi, M. Barbanti, and M.R. Milani et al. Protein C deficiency in insulin-dependent diabetes: A hyperglycemia-related phenomenon Thrombosis and haemostasis 64 1 1990 104 107
8. B. Dahlback, and B.O. Villoutreix Molecular recognition in the protein C anticoagulant pathway Journal of thrombosis and haemostasis 1 7 2003 1525 1534
9. J. Duchemin, B. Pan-Petesch, B. Arnaud, M.T. Blouch, and J.F. Abgrall Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma Thrombosis and haemostasis 99 4 2008 767 773
10. C. Erem, A. Hacihasanoglu, S. Celik, E. Ovali, H.O. Ersöz, and K. Ukinç et al. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications Medical principles and practice 14 1 2005 22 30
11. P. Ferroni, D. Della-Morte, A. Pileggi, M.G. Valente, F. Martini, and F. La Farina et al. Impact of statins on the coagulation status of type 2 diabetes patients evaluated by a novel thrombin-generation assay Cardiovascular drugs and therapy 26 4 2012 301 309
12. G. Hron, M. Kollars, B.R. Binder, S. Eichinger, and P.A. Kyrle Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation JAMA: the journal of the American Medical Association 296 4 2006 397 402
13. T.W. Jax, A.J. Peters, G. Plehn, and F.C. Schoebel Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - A two year follow-up of 243 patients Cardiovascular diabetology 8 48 2009 1 10
14. K. Masamura, K. Oida, H. Kanehara, J. Suzuki, S. Horie, and H. Ishii et al. Pitavastatin-induced thrombomodulin expression by endothelial cells acts via inhibition of small G proteins of the Rho family Arteriosclerosis thrombosis and vascular biology 23 3 2003 512 517
15. T. Matsumoto, M. Shima, M. Takeyama, K. Yoshida, I. Tanaka, and Y. Sakurai et al. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay Journal of thrombosis and haemostasis 4 2 2006 377 384
16. M. Pastuszczak, A. Kotlarz, M. Mostowik, J. Zalewski, K. Zmudka, and K. Zmudka et al. Prior simvastatin treatment is associated with reduced thrombin generation and platelet activation in patients with acute ST-segment elevation myocardial infarction Thrombosis research 125 5 2010 382 386
17. D.L. Sauls, A.E. Banini, L.C. Boyd, and M. Hoffman Elevated prothrombin level and shortened clotting times in subjects with type 2 diabetes Journal of thrombosis and haemostasis 5 3 2007 638 639
18. J.W. Seo, H.K. Kim, J.E. Kim, S. Park, and H.I. Cho Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation Thrombosis research 123 4 2009 565 572
19. D.W. Sommeijer, H.R. Hansen, R. van Oerle, K. Hamulyak, A.P. van Zanten, and E. Meesters et al. Soluble tissue factor is a candidate marker for progression of microvascular disease in patients with Type 2 diabetes Journal of thrombosis and haemostasis 4 3 2006 574 580
20. A. Szczeklik, J. Musial, A. Undas, P. Gajewski, P. Góra, and J. Swadźba et al. Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia Journal of the American College of Cardiology 33 5 1993 1286 1293
21. A. Szczeklik, J. Musial, A. Undas, J. Swadzba, P.F. Gora, and W. Piwowarska et al. Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia Arteriosclerosis, thrombosis, and vascular biology 16 8 1996 948 954
22. A. Tripodi, A. Branchi, V. Chantarangkul, M. Clerici, G. Merati, and A. Artoni et al. Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay Journal of thrombosis and thrombolysis 31 2 2011 165 172
23. A. Tripodi, C. Legnani, V. Chantarangkul, B. Cosmi, G. Palareti, and P.M. Mannucci High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism Journal of thrombosis and haemostasis 6 8 2008 1327 1333
24. A. Undas, K.E. Brummel-Ziedins, and K.G. Mann Statins and blood coagulation Arteriosclerosis thrombosis & vascular biology 25 2 2005 287 294
25. C.J. Verkleij, R.E. Bruijn, E.W. Meesters, V.E. Gerdes, J.C. Meijers, and P.F. Marx The hemostatic system in patients with type 2 diabetes with and without cardiovascular disease Clinical and applied thrombosis/hemostasis 17 6 2011 E57 E63
26. A. Vinik, and M. Flemmer Diabetes and macrovascular disease Journal of diabetes and its complications 16 3 2002 235 245
27. T. Yamada, A. Sato, T. Nishimori, T. Mitsuhashi, A. Terao, and H. Sagai et al. Importance of hypercoagulability over hyperglycemia for vascular complication in type 2 diabetes Diabetes research and clinical practice 49 1 2000 23 31
28. Y. Zhao, J. Zhang, J. Zhang, and J. Wu Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values PLoS One 6 1 2011 e16470